Total Valuation
Natural Beauty Bio-Technology has a market cap or net worth of $114.85M. The enterprise value is $1.23K.
Market Cap$114.85M
Enterprise Value$1.23K
Share Statistics
Natural Beauty Bio-Technology has 2,002,101,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,002,101,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Natural Beauty Bio-Technology’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.60%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)2.60%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee902.56K
Profits Per Employee17.72K
Employee Count597
Asset Turnover0.58
Inventory Turnover2.58
Valuation Ratios
The current PE Ratio of Natural Beauty Bio-Technology is ―. Natural Beauty Bio-Technology’s PEG ratio is -0.84.
PE Ratio―
PS Ratio1.82
PB Ratio2.07
Price to Fair Value2.07
Price to FCF-10.45
Price to Operating Cash Flow-15.45
PEG Ratio-0.84
Income Statement
In the last 12 months, Natural Beauty Bio-Technology had revenue of 538.83M and earned 10.58M in profits. Earnings per share was <0.01.
Revenue538.83M
Gross Profit293.34M
Operating Income23.18M
Pretax Income11.82M
Net Income10.58M
EBITDA57.78M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was -58.33M and capital expenditures -78.56M, giving a free cash flow of -136.88M billion.
Operating Cash Flow-58.33M
Free Cash Flow-136.88M
Free Cash Flow per Share-0.07
Dividends & Yields
Natural Beauty Bio-Technology pays an annual dividend of <$0.001, resulting in a dividend yield of 0.48%
Dividend Per Share<$0.001
Dividend Yield0.48%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.30
52-Week Price Change-20.63%
50-Day Moving Average0.06
200-Day Moving Average0.06
Relative Strength Index (RSI)0.92
Average Volume (3m)271.00
Important Dates
Natural Beauty Bio-Technology upcoming earnings date is Mar 24, 2027, TBA (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateMar 24, 2027
Ex-Dividend Date―
Financial Position
Natural Beauty Bio-Technology as a current ratio of 1.11, with Debt / Equity ratio of 100.27%
Current Ratio1.11
Quick Ratio0.81
Debt to Market Cap0.30
Net Debt to EBITDA3.72
Interest Coverage Ratio2.21
Taxes
In the past 12 months, Natural Beauty Bio-Technology has paid 1.24M in taxes.
Income Tax1.24M
Effective Tax Rate0.10
Enterprise Valuation
Natural Beauty Bio-Technology EV to EBITDA ratio is 20.70, with an EV/FCF ratio of -12.74.
EV to Sales2.22
EV to EBITDA20.70
EV to Free Cash Flow-12.74
EV to Operating Cash Flow-46.61
Balance Sheet
Natural Beauty Bio-Technology has $116.16M in cash and marketable securities with $424.66M in debt, giving a net cash position of -$308.50M billion.
Cash & Marketable Securities$116.16M
Total Debt$424.66M
Net Cash-$308.50M
Net Cash Per Share-$0.15
Tangible Book Value Per Share$0.24
Margins
Gross margin is 43.42%, with operating margin of 4.30%, and net profit margin of 1.96%.
Gross Margin43.42%
Operating Margin4.30%
Pretax Margin2.19%
Net Profit Margin1.96%
EBITDA Margin10.72%
EBIT Margin5.08%
Analyst Forecast
The average price target for Natural Beauty Bio-Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast13.13%
EPS Growth Forecast7.50%